U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TENGONERMIN
2YQ0811D7K
Investigational
General
Names
4
Classification
1
Identifiers
6
Subunits
3
Related Substances
1
TENGONERMIN
2YQ0811D7K
Investigational
General
Approval Year
Unknown
149,124
Names
4
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
TENGONERMIN
Official Name
English
GLYCINE, L-CYSTEINYL-L-ASPARAGINYLGLYCYL-L-ARGINYL-L-CYSTEINYL- FUSION PROTEIN WITH TUMOR NECROSIS FACTOR .ALPHA. (HUMAN N-TERMINAL FRAGMENT), TRIMER
Preferred Name
English
tengonermin [INN]
Common Name
English
NGR-hTNF [WHO-DD]
Common Name
English
Showing 1 to 4 of 4 entries
Previous
1
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Positive
EU ORPHAN DRUG
Positive
Treatment of hepatocellular carcinoma
EU-Orphan Drug
EU/3/09/686
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
2YQ0811D7K
PRIMARY
SMS_ID
100000181749
PRIMARY
NCI_THESAURUS
C166607
PRIMARY
CAS
1960461-99-7
PRIMARY
INN
10606
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Subunits
3
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Related Substances
1
ACTIVE MOIETY
2YQ0811D7K
TENGONERMIN
